Alnylam Pharmaceuticals Inc R&D Day 2019 Transcript
Good morning. I'm Christine Lindenboom, the Head of Investor Relations and Corporate Communications at Alnylam. We're thrilled to have you here at our R&D Day in what has been a very, very exciting week for Alnylam.
As you'll see throughout the course of the day, we have actually a very full packed agenda with a range of topics talking about both our late-stage clinical programs, some of the thoughts around self-sustainability as well as some of our earlier stage clinical programs as well. We plan to end around 12:40 based on the current agenda.
Just a couple of brief reminders for everyone. There will be breaks throughout the course of the day. There is food and coffee out in the foyer. We do ask you to silence your cell phones to minimize interruptions for our presenters. There will also be a box lunch for everyone to take as you go, and the slides, as we typically do, will be made available actually right now on the Capella website on alnylam.com.
And then just a quick reminder
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
